Prion Diseases

Overview of CJD and other prion diseases.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Neurology

Clinical Guidelines

CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products (EMA)
National
CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products (Revision 2)
National
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia
National
Health Technical Memorandum 01-01. Part A: Management and decontamination of surgical instruments (medical devices) used in acute care
National
Infection control of CJD, vCJD and other human prion diseases in healthcare and community settings (ACDP TSE Risk Management Subgroup Guidance)
National
World Health Organization: WHO infection control guidelines for transmissible spongiform encephalopathies (TSEs)
National
World Health Organization: WHO infection control guidelines for transmissible spongiform encephalopathies (TSEs), including prion diseases
National
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings
Local
Clinical Testing Guidance for Blood Safety: Prion Diseases
Local
Disinfection and Sterilization of Prion-Contaminated Medical Instruments (SHEA Guideline)
Local
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia
Local
Guideline for disinfection and sterilization of prion-contaminated medical instruments
Local
Guidelines for Environmental Infection Control in Health-Care Facilities
Local
Prion Disease Reporting and Investigation Guideline
Local
Review of guidelines for prevention of Creutzfeldt–Jakob disease transmission in healthcare settings (ECDC)
Local